Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMID 12411224)

Published in Am J Psychiatry on November 01, 2002

Authors

Irena Nulman1, Joanne Rovet, Donna E Stewart, Jacob Wolpin, Pia Pace-Asciak, Samar Shuhaiber, Gideon Koren

Author Affiliations

1: Motherisk Program, Division of Pediatrics and Psychology and the Reseaarch Institute, The Hospital for Sick Children, Toronta, Ont. Canada.

Associated clinical trials:

Transcranial Direct Current Stimulation (tDCS) for Depression in Pregnancy: A Pilot Study | NCT02116127

Articles citing this

Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry (2009) 3.94

The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol (2009) 3.52

The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry (2009) 2.01

Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology (2006) 1.83

Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand (2012) 1.75

Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function. J Clin Psychiatry (2016) 1.43

Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol (2006) 1.43

Maternal depression and infant cortisol: influences of timing, comorbidity and treatment. J Child Psychol Psychiatry (2008) 1.38

Depression during pregnancy. Can Fam Physician (2005) 1.29

Perinatal depression: treatment options and dilemmas. J Psychiatry Neurosci (2008) 1.22

Maternal depression and child development. Paediatr Child Health (2004) 1.16

Update on environmental risk factors for attention-deficit/hyperactivity disorder. Curr Psychiatry Rep (2011) 1.15

Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci (2008) 1.13

Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation. BJOG (2008) 1.10

Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology (Berl) (2011) 1.08

Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus. Neuropsychopharmacology (2011) 1.05

Early life programming as a target for prevention of child and adolescent mental disorders. BMC Med (2014) 1.00

Antenatal depression and children's developmental outcomes: potential mechanisms and treatment options. Eur Child Adolesc Psychiatry (2014) 1.00

Antidepressant medication use during breastfeeding. Clin Obstet Gynecol (2009) 0.99

Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies. J Musculoskelet Neuronal Interact (2008) 0.99

Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One (2011) 0.99

A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure. J Clin Psychiatry (2011) 0.98

Plasma melatonin circadian rhythm disturbances during pregnancy and postpartum in depressed women and women with personal or family histories of depression. Am J Psychiatry (2008) 0.97

Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol (2013) 0.97

Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention? J Child Psychol Psychiatry (2011) 0.95

The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. Front Cell Neurosci (2013) 0.94

Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age. Front Cell Neurosci (2013) 0.94

Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors. Neuropsychopharmacology (2014) 0.93

Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict (2009) 0.92

Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology (Berl) (2011) 0.91

Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review. Eur Child Adolesc Psychiatry (2014) 0.89

Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses. Br J Clin Pharmacol (2012) 0.89

Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis. PLoS One (2014) 0.89

Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat? Obstet Gynecol Int (2011) 0.88

Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 1: Literature review. Br J Clin Pharmacol (2012) 0.87

Evidence that the deficit in sexual behavior in adult rats neonatally exposed to citalopram is a consequence of 5-HT1 receptor stimulation during development. Brain Res (2006) 0.85

Antidepressant use in pregnant and postpartum women. Annu Rev Clin Psychol (2013) 0.85

Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI). BMC Psychiatry (2012) 0.84

Neurodevelopmental outcome for offspring of women treated for antenatal depression: a systematic review. Arch Womens Ment Health (2014) 0.83

Ethical issues in child psychopharmacology research and practice: emphasis on preschoolers. Psychopharmacology (Berl) (2007) 0.83

Pregnancy, depression, antidepressants and breast-feeding. J Psychiatry Neurosci (2006) 0.83

Safety of treatment of obsessive compulsive disorder in pregnancy and puerperium. Can Fam Physician (2014) 0.81

Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure. Curr Neuropharmacol (2011) 0.81

Mood disorders and their pharmacological treatment during pregnancy: is the future child affected? Pediatr Res (2011) 0.80

Dose-dependent effects of neonatal SSRI exposure on adult behavior in the rat. Brain Res (2011) 0.80

Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblings. Int J Epidemiol (2015) 0.80

Maternal mental health in primary care in five low- and middle-income countries: a situational analysis. BMC Health Serv Res (2016) 0.79

Fluoxetine impairs GABAergic signaling in hippocampal slices from neonatal rats. Front Cell Neurosci (2013) 0.78

Medications for panic disorder and generalized anxiety disorder during pregnancy. Prim Care Companion J Clin Psychiatry (2005) 0.78

Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior. Pediatr Res (2015) 0.77

Association Between Antidepressants Use During Pregnancy and Autistic Spectrum Disorders: A Meta-analysis. Innov Clin Neurosci (2014) 0.77

Long-term effects of fluoxetine or vehicle administration during pregnancy on behavioral outcomes in guinea pig offspring. Psychopharmacology (Berl) (2004) 0.76

Treatment with selective serotonin reuptake inhibitors during pregnancy: deceleration of weight gain because of depression or drug? Am J Psychiatry (2006) 0.76

Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges. Drug Healthc Patient Saf (2014) 0.76

Diagnosing and Treating Depression During Pregnancy. Prim Care Companion CNS Disord (2015) 0.75

Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation. Indian J Psychiatry (2015) 0.75

Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise. Psychopharmacology (Berl) (2013) 0.75

Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research. Int J Dev Neurosci (2016) 0.75

Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression. Psychopharmacology (Berl) (2016) 0.75

Returning to tricyclic antidepressants for depression during childbearing: clinical and dosing challenges. Arch Womens Ment Health (2014) 0.75

Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database. Br J Clin Pharmacol (2016) 0.75

A patient decision aid for antidepressant use in pregnancy: study protocol for a randomized controlled trial. Trials (2016) 0.75

Pharmacological management of panic disorder. Neuropsychiatr Dis Treat (2008) 0.75

Maternal Prenatal Psychological Distress and Preschool Cognitive Functioning: the Protective Role of Positive Parental Engagement. J Abnorm Child Psychol (2016) 0.75

Perceptual interference processing in preschool children, with and without prenatal exposure to selective serotonin reuptake inhibitors. Psychopharmacology (Berl) (2016) 0.75

Articles by these authors

Prevalence of depression during pregnancy: systematic review. Obstet Gynecol (2004) 5.42

Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2012) 4.64

Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry (2004) 4.52

Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry (2013) 3.71

Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol (2013) 3.68

The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol (2009) 3.52

Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. J Pediatr (2011) 2.86

Variables associated with medication errors in pediatric emergency medicine. Pediatrics (2002) 2.86

Breast and cervical cancer screening in Hispanic women: a literature review using the health belief model. Womens Health Issues (2002) 2.79

Effects of screening for psychological distress on patient outcomes in cancer: a systematic review. J Psychosom Res (2013) 2.78

Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can (2007) 2.64

Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin Pharmacol Ther (2002) 2.53

Perinatal risks of untreated depression during pregnancy. Can J Psychiatry (2004) 2.50

Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology (2014) 2.41

Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med (2002) 2.32

Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol (2012) 2.23

Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry (2008) 2.22

Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr (2013) 2.18

The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG (2004) 2.04

The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol (2009) 2.03

FDA pregnancy risk categories and the CPS: do they help or are they a hindrance? Can Fam Physician (2010) 2.02

Effectiveness of the Antenatal Psychosocial Health Assessment (ALPHA) form in detecting psychosocial concerns: a randomized controlled trial. CMAJ (2005) 2.02

Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry (2008) 2.01

The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry (2009) 2.01

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry (2005) 2.00

Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. CMAJ (2005) 1.99

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin Ther (2007) 1.98

Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J Clin Invest (2008) 1.93

Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther (2003) 1.91

Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit (2003) 1.91

Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin Invest Med (2007) 1.91

Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit (2009) 1.89

Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry (2012) 1.88

Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Can Fam Physician (2007) 1.83

Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril (2006) 1.80

Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells (2008) 1.78

Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions. Psychoneuroendocrinology (2011) 1.78

Child neurodevelopmental outcome and maternal occupational exposure to solvents. Arch Pediatr Adolesc Med (2004) 1.77

Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can (2009) 1.76

Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. Am J Epidemiol (2009) 1.72

Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review. Reprod Toxicol (2007) 1.70

Historical perspective: the original description of fetal alcohol spectrum disorder in France, 1967. Ther Drug Monit (2003) 1.68

The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.67

The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.66

Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry (2013) 1.65

Pregnancy outcome following non-obstetric surgical intervention. Am J Surg (2005) 1.65

Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. Am J Surg (2009) 1.65

Cardiac rehabilitation II: referral and participation. Gen Hosp Psychiatry (2002) 1.64

More codeine fatalities after tonsillectomy in North American children. Pediatrics (2012) 1.63

Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology (2005) 1.62

Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm (2012) 1.62

Counseling about medication-induced birth defects with clinical decision support in primary care. J Womens Health (Larchmt) (2013) 1.60

Pregnancy and isotretinoin therapy. CMAJ (2013) 1.60

Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf (2002) 1.58

Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychol (2004) 1.58

Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med (2009) 1.57

Discrepancies between ordered and delivered concentrations of opiate infusions in critical care. Crit Care Med (2003) 1.55

Hair mercury levels of women of reproductive age in Ontario, Canada: implications to fetal safety and fish consumption. J Pediatr (2010) 1.52

Breast-feeding during maternal use of azathioprine. Ann Pharmacother (2006) 1.52

Lifestyle interference and emotional distress in family caregivers of advanced cancer patients. Cancer (2002) 1.51

Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. Heart Rhythm (2013) 1.50

A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145]. BMC Pregnancy Childbirth (2006) 1.50

Effect of depression on five-year mortality after an acute coronary syndrome. Am J Cardiol (2005) 1.48

Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother (2003) 1.48

Renin-angiotensin blockade is associated with increased mortality after vascular surgery. Can J Anaesth (2010) 1.46

Hair methylmercury: a new indication for therapeutic monitoring. Ther Drug Monit (2010) 1.44

Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med (2002) 1.44

Safety of the newer class of opioid antagonists in pregnancy. Can Fam Physician (2014) 1.43

Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila) (2010) 1.43

Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. Am J Obstet Gynecol (2011) 1.43

Evaluation of drug formularies for pediatric intensive care. Pediatr Crit Care Med (2011) 1.42

Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. AJR Am J Roentgenol (2004) 1.42

Patterns of paediatric analgesic use in Africa: a systematic review. Arch Dis Child (2012) 1.42

The role of work stress as a moderating variable in the chronic pain and depression association. J Psychosom Res (2006) 1.42

Timolol concentrations in breast milk of a woman treated for glaucoma: calculation of neonatal exposure. J Glaucoma (2008) 1.41

Tdap vaccination during pregnancy to reduce pertussis infection in young infants. Can Fam Physician (2013) 1.40

Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov. J Clin Pharmacol (2013) 1.40

Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol (2012) 1.40

Examining the health and drug exposures among Canadian children residing in drug-producing homes. J Pediatr (2011) 1.39

Electric shock during pregnancy. Can Fam Physician (2003) 1.39

Influenza vaccination during pregnancy. Can Fam Physician (2002) 1.39

"Cardiac memory": a struggle against forgetting. Circ Res (2003) 1.39

Eating fish during pregnancy. Risk of exposure to toxic levels of methylmercury. Can Fam Physician (2002) 1.37

What is resilience? Can J Psychiatry (2011) 1.37

Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department. BMJ (2004) 1.35

Modulation of celecoxib pharmacokinetics by food in pediatric patients. Clin Pharmacol Ther (2005) 1.33

Automatic referral to cardiac rehabilitation. Med Care (2004) 1.33

Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ (2009) 1.32

Effects of prenatal alcohol exposure on hippocampal volume, verbal learning, and verbal and spatial recall in late childhood. J Int Neuropsychol Soc (2008) 1.30

Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol (2005) 1.29

Treatment of nausea and vomiting in pregnancy: an updated algorithm. Can Fam Physician (2007) 1.29

Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ (2014) 1.28

Exploration of the relationship between household food insecurity and diabetes in Canada. Diabetes Care (2009) 1.26

Computer-assisted screening for intimate partner violence and control: a randomized trial. Ann Intern Med (2009) 1.26

The relationship between stress and hair cortisol in healthy pregnant women. Clin Invest Med (2007) 1.26

Systematic evaluation of errors occurring during the preparation of intravenous medication. CMAJ (2008) 1.26

Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol (2002) 1.25